Roche Pharma Sales Beat Q3 Consensus Forecast by CHF 350 Million

Group sales rose 8% in Swiss francs to CHF 16.13 billion, and Roche kept its 2026 growth outlook.
This is a short summary. The full story is published by Econotimes.
Read full story at Econotimes


